Page 1 of Clinical Trials for ViiV Healthcare [SPONSOR-COLLABORATORS], 89 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
Last Updated: May 10, 2012
Condition(s): Human Immunodeficiency Virus (HIV)
2
Withdrawn
Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients
Last Updated: January 18, 2012
Condition(s): Hepatitis B; Human Immunodeficiency Virus; Hepatitis C, Chronic
3
Enrolling by invitation
Kaiser Permanente HIV Cohort Study
Last Updated: May 10, 2012
Condition(s): HIV; AIDS
4
Completed
A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects
Last Updated: January 3, 2012
Condition(s): HIV Infection; Infection, Human Immunodeficiency Virus
5
Completed
Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
Last Updated: April 2, 2012
Condition(s): HIV Infections
6
Completed
Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects
Last Updated: June 27, 2011
Condition(s): Healthy
7
Completed
A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients
Last Updated: October 19, 2011
Condition(s): Human Immunodeficiency Virus-1
8
Terminated
Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects
Last Updated: February 3, 2011
Condition(s): Healthy
9
No longer available
A Compassionate Access Protocol For Those Patients Who Have Completed A4001029
Last Updated: July 21, 2011
Condition(s): HIV
10
Active, not recruiting
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
Last Updated: March 29, 2012
Condition(s): HIV Infection; Infection, Human Immunodeficiency Virus; HIV-1 Infection
11
Active, not recruiting
A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)
Last Updated: May 10, 2012
Condition(s): Infection, Human Immunodeficiency Virus I
12
Active, not recruiting
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
Last Updated: May 17, 2012
Condition(s): Infection, Human Immunodeficiency Virus
13
Enrolling by invitation
HIV Cohort Study At Johns Hopkins University, University of North Carolina at Chapel Hill and Vanderbilt University
Last Updated: May 10, 2012
Condition(s): HIV; AIDS
14
Completed
Dolutegravir Renal Impairment Study
Last Updated: April 26, 2012
Condition(s): Infection, Human Immunodeficiency Virus
15
Completed
A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435
Last Updated: September 8, 2011
Condition(s): Infections, Human Immunodeficiency Virus and Herpesviridae; Infection, Human Immunodeficiency Virus
16
Completed
Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
Last Updated: March 29, 2012
Condition(s): HIV Infection; Infection, Human Immunodeficiency Virus
17
Completed
Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.
Last Updated: April 5, 2012
Condition(s): Infections, Human Immunodeficiency Virus and Hepatitis
18
Completed
Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
Last Updated: April 16, 2012
Condition(s): HIV Infections
19
Withdrawn
Maraviroc Compassionate Use
Last Updated: November 10, 2010
Condition(s): Human Immunodeficiency Virus Type 1
20
Completed
A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily
Last Updated: April 5, 2012
Condition(s): Infection, Human Immunodeficiency Virus I

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=ViiV+Healthcare

Page 1 of Clinical Trials for ViiV Healthcare [SPONSOR-COLLABORATORS], 89 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About